Peter Halperin, M.D.
NPI 1487727541 · Dermatology Physician · New York, NY
Peter Halperin, M.D. is a Dermatology Physician provider in New York, NY (NPI 1487727541).
Provider details
- NPI number
- 1487727541
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 174932-1 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,684 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 734 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 562 | $96 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 533 | $60 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 288 | $64 |
| Biopsy of Related Skin Growth, First Growth11102 | 240 | $105 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluorouracil | 121 | 107 |
| Ketoconazole | 120 | 59 |
| Triamcinolone Acetonide | 107 | 89 |
| Mometasone Furoate | 106 | 91 |
| Calcipotriene | 98 | 85 |
| Metronidazole | 77 | 36 |
| Ciclopirox | 73 | 39 |
| Hydrocortisone | 64 | 49 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,574 across 94 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-11-16
- Last updated
- 2007-07-08
Frequently asked questions
- What is Peter Halperin's NPI number?
- Peter Halperin's National Provider Identifier (NPI) is 1487727541, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Peter Halperin's specialty?
- Peter Halperin is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Peter Halperin located?
- Peter Halperin's practice location on file with NPPES is 115 E 61st St, New York, NY 10021-8183.
- What is Peter Halperin's phone number?
- The practice phone number listed in the NPPES registry for Peter Halperin is (212) 759-7447.
- Is Peter Halperin's NPI active?
- Yes — Peter Halperin's NPI (1487727541) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.